ArticleActa pharmacologica Sinica2023

Discovery of toxoflavin, a potent IRE1α inhibitor acting through structure-dependent oxidative inhibition.

Kai-Long Jiang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.